Cancer diagnostics company Pacific Edge (NZX, ASX: PEB, the ‘Company’) today announces an offer to raise up to NZ$24 million at NZ$0.170 per share consisting of a placement of NZ$18 million new ordinary shares to eligible investors and an offe

Synlait Milk Limited (Synlait) advises that Independent Director Paul McGilvary has provided notice of his resignation from the Board

Fletcher Building advises that its Laminex AU business unit has entered into a conditional agreement to sell its property located in Cheltenham, Melbourne, Australia, to Forza Capital for A$53.8 million

Comvita Limited (NZX: CVT) is pleased to advise that its pro-rata renounceable Rights Offer announced on 15 April 2026 has achieved its minimum capital raise threshold (when taking into account F&N’s Shortfall Commitment)

US equities finished the week mixed, with strength in Tech offsetting weakness in industrials. The S&P 500 rose 0.3%, the Nasdaq gained 0.9%, both closing at record highs, while the Dow Jones slipped 0.3% as defensives and cyclicals lagged

What does this mean for the outlook for the New Zealand and Australian stock markets?

If you have listed NZX and ASX investments and you are in the process of reassessing your holdings or wish to do so, our advisers at Equity Investment Advisers Limited are willing to assist. As you are no doubt aware most markets are fully priced, and som